We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Stem Cell Therapy Repairs Heart Defect in Mouse Model

By LabMedica International staff writers
Posted on 23 Sep 2008
Cardiovascular disease researchers have used stem cells to repair damaged heart muscle in a mouse model of dilated cardiomyopathy, a potentially fatal, congenital heart defect.

Investigators at the Mayo Clinic (Rochester, MN, USA) developed a mouse line where the gene for critical heart-protective proteins called ATP-sensitive (KATP) channel subunits was "knocked-out.” The animals mimicked the symptoms of human dilated cardiomyopathy, typified by poor survival due to compromised heart contractions and ventricular dilation.

In an attempt to repair this condition, the investigators transplanted 200,000 embryonic stem cells into the wall of the left ventricle of the knockout mice. More...
They reported in the July 31, 2008, online edition of the journal Stem Cells that after one month the treatment improved heart performance, synchronized electrical impulses, and stopped heart deterioration. The presence of the lacZ reporter transgene in the rejuvenated heart tissue showed that the stem cells had grafted into the heart to form new cardiac tissue. Stem cell transplantation restarted cell cycle activity in the heart tissue and reduced fibrosis by 50%. Improved systemic function induced by the stem cell therapy translated into increased stamina, absence of swelling due to the accumulation of serous fluids, and benefit to overall survivorship.

"We have shown in this transgenic animal model that embryonic stem cells may offer an option in repairing genetic heart problems,” said first author Dr. Satsuki Yamada, cardiovascular researcher at the Mayo Clinic.

Related Links:
Mayo Clinic



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.